Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
公式(I)的化合物:(其中变量基团如定义)药用可接受的盐、溶剂化合物、该类盐的溶剂化合物及其前药,以及它们作为治疗高脂血症的
胆固醇吸收
抑制剂的用途已经描述。还描述了它们的制备方法和含有它们的药物组合物。